Accelerated CAD after TAVR is an issue. This 23mm CoreValve was done <3 years ago, in a small female. How would you approach? Guide choice? Atherectomy? Stent strategy? 🙏

92 year old pt with CoreValve 9 yrs ago. Now with SHD (AI) and no fem access. Shockwave in the iliac-fem to allow local anaest. and perc. approach. TAVR in TAVR.
S3 26 in CoreValve 29 at node 5. Thoughts?
Maurizio taramasso thomas modine Dr. Gilbert Tang Matias Sztejfman Pablo Lamelas 🇦🇷🇨🇦

We treated this using a 29 corevalve fx with excellent results. Discharged home 2 days later. Medtronic Structural Heart Jeffrey Popma

Reuniting with an old friend (Medtronic), TAVI to 74 years old gentleman with prior mechanical MVR using 34 mm CoreValve, ended with satisfactory result. #CardioTwitter #TAVI Turkish Society of Cardiology #MedTwitter #yapisal kalp #kardiyoloji #yapisal #yapisal kalp hastaliklari

Which devices are associated with the most payments to interventional cardiologists in the US? Focusing on the 2013-2022 period, thery are: CoreValve/Evolut (roughly $45 million), Impella (roughly $30 million), Sapien 3 (roughly $25 million), Watchman (roughly $20 million), and

#CRT2023

#LBT #corevalve has less deterioration than #SVR at 5y

BCaseMD Luis Ortega Paz Jorge Sanz Sánchez Davide Capodanno CRT Meeting Hector Garcia Kalyan Chitturi CRMjournal Mamas A. Mamas Bailey Ann Estes MIЯVΛƬ #IC Srihari S. Naidu, MD Ankur Kalra Hayder Hashim Giorgio A. Medranda MD, FACC, FAHA, FSCAI

Primer Implante Valvular Aórtico Transcarotideo Exitoso Con válvula CoreValve Evolut Pro + con Delivery System el IADT a la vanguardia en el tratamiento de la Cardiopatía Estructural . Agradecimiento a todo el gran equipo que lo hizo posible !!!❤️

Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis

low incidence of reintervention was observed for CoreValve/Evolut R/PRO and SAVR through 5 years.

jacc.org/doi/10.1016/j.…

Finalizando el año realizando los dos primeros implantes valvulares aórticos transcarotideos de la Argentina con válvula corevalve Evolut pro + , Caso muy difícil, Excesiva tortuosidad . Trabajo realizado por un gran equipo. El IADT a la vanguardia del tratamiento Endovascular .

CoreValve 29mm implanted October 2011…still going strong after 12 years…mean gradient 6mmhg and trace PVL in June 2023…
The future is promising
Atlantic Health Medtronic Edwards TAVR TAVR Bot David J. Cohen, MD, MSc Linda Gillam MD, MPH, MACC, FASE, FAHA, FESC Jordan Safirstein MD Dr. Gilbert Tang Michael Katz Philippe Genereux

The best durability: our #TAVR platform had significantly better BVD at 5 yrs vs. SAVR, driven by 2x lower SVD (2.2% TAVR vs. 4.4% SAVR, p<0.01) & 3x lower severe PPM. bit.ly/430eDZ4

Risk info: bit.ly/42UhBOx. Devices: CoreValve 88%/Evolut R 12%

📌NOTION trial. Rv Ao biológico🆚TAVI (CoreValve). Seguimiento 10 años.

🔸ECR. 280 👥bajo riego (STS-PROM 3)
🔹79 años, 47% ♀️

🏁Sin diferencias en muerte total & en💔IAM, muerte total y stroke🧠.
⬆️Deterioro hemodinámico severo en bioprótesis.
⬆️FA en Cx &⬆️marcapasos en TAVI

Breaking at #ESCCongress : CoreValve™ #TAVR platform demonstrates statistically better durability versus surgery at 10 years in patients at lower surgical risk over the age of 70. Devices used: CoreValve 100%. Risk info: bit.ly/44BsMvl

Matrioska works.
#ValveInValveInValve
Lilian Grigorian Francisco Fernández-Avilés
Hospital San Rafael, HSJD.
Carpentier-Edwards > CoreValve Medtronic > Edwards Sapiens

Implantación directa trans-aórtica de prótesis CoreValve en paciente con estenosis aórtica crítica y múltiples comorbilidades. 🫀 Procedimiento híbrido efectuado en Hospital Cruz Roja de Córdoba.
#CardioTwitter #Cardiology
Caso completo ⬇️
bit.ly/3LvSwTq

En el Informe anual 2022, la palabra TAVR aparece 3 veces en el caso de Medtronic (principal competidor) vs. 50 veces en el caso de $EW.

El principal producto de Medtronic (CoreValve) aparece 4 veces en el informe anual vs. 98 veces la parabra SAPIEN en el caso de $EW

According to a pooled analysis encompassing 5,925 TAVR and 1,832 SAVR patients, a low incidence of reintervention was observed for CoreValve/Evolut R/PRO and SAVR through 5 years. Notably, reintervention occurred most often at ≤1 year for TAVR and >1 year for SAVR, and were

#TCT2023

Reintervention occurred most often at <1 year for #TAVR and at >1 year for #SAVR . The majority of early reinterventions were with first-generation #CoreValve and managed percutaneously. #Evolut R/PRO valves required fewer reinterventions than CoreValve, with rates

In this analysis of the SCOPE-2 randomised trial, the authors found that new conduction abnormalities and new permanent pacemaker implantation were significantly lower after TAVI when using the ACURATE neo valve compared to the CoreValve Evolut valve. ow.ly/R34g50MPLL0

European Society of Cardiology 10y NOTION #TAVR vs SAVR with CoreValve, <=> death, combined death, stroke, MI but #TAVR lower severe SVD, <=> BVF. 1st data showring LT TAVR durability Didier Tchetche SahilKheraMD Lucy vinayak bapat Azeem Latib Kendra J. Grubb M.D. MIЯVΛƬ #IC David J. Cohen, MD, MSc TCTMD